Press release
Traumatic Brain Injury Pipeline Insights 2024: Therapies, Clinical Trials, and Treatment Outlook | Neuren Pharma, NeuroVive Pharma, Stemedica Cell Techn, Grace Laboratories, Integra LifeSciences Corp
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Traumatic Brain Injury pipeline constitutes key companies continuously working towards developing Traumatic Brain Injury treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight."Traumatic Brain Injury Pipeline Insight, 2024 [https://www.delveinsight.com/sample-request/traumatic-brain-injury-tbi-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Traumatic Brain Injury Market.
The Traumatic Brain Injury Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Traumatic Brain Injury Pipeline Report:
*
Companies across the globe are diligently working toward developing novel Traumatic Brain Injury treatment therapies with a considerable amount of success over the years.
*
Traumatic Brain Injury companies working in the treatment market are SHINKEI Therapeutics, Inc, Hope Biosciences, CereMark Pharma, LLC, Abalonex, LLC, Hamad Medical Corporation, Supernus Pharmaceuticals, Inc., Merz Pharmaceuticals GmbH, Odyssey Group, Pinteon Therapeutics, Vasopharm, SanBio, NeuroTrauma Sciences, ALSP Inc., AlzeCure, and others, are developing therapies for the Traumatic Brain Injury treatment
*
Emerging Traumatic Brain Injury therapies in the different phases of clinical trials are- Amantadine Hydrochloride, HB-adMSCs, [F-18]Flornaptitril, ABX-101, Propranolol, MYOBLOC, NT 201, PRV 002, PNT001, VAS203, Vandefitemcel, NTS-105, Research Program, ACD856, and others are expected to have a significant impact on the Traumatic Brain Injury market in the coming years.
*
In October 2024, Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) announced its plans to initiate a new clinical trial in collaboration with the University of California, San Diego (UCSD). Led by Dr. Ming Xiong Huang, the UCSD principal investigator, the study will recruit patients, including those affected by Traumatic Brain Injury (TBI), through the San Diego VA. The trial will assess the effectiveness of Nexalin's next-generation Gen-3 Halo headset, designed for use in a virtual clinic model. This approach allows patients to receive treatment from the comfort of their own homes, helping eliminate the challenges of visiting psychiatric offices or VA hospitals. The goal is to improve access to care for veterans with mild Traumatic Brain Injury (mTBI), minimizing the need for frequent hospital or clinic visits.
*
In April 2024, The SanBio Group (SanBio Co., Ltd. and SanBio, Inc.), a leader in regenerative medicine for neurological conditions, announced that SB623, a regenerative cell therapy being developed globally to treat chronic motor deficits caused by traumatic brain injury (TBI), has been granted Sakigake Designation by Japan's Ministry of Health, Labour, and Welfare (MHLW) for innovative medical products.
Traumatic Brain Injury Overview
Traumatic Brain Injury (TBI) is a disruption in normal brain function caused by an external force, such as a blow, jolt, or penetrating injury to the head. It can range from mild (concussion) to severe, potentially leading to long-term cognitive, physical, and emotional impairments. Common causes include falls, motor vehicle accidents, and sports injuries. Symptoms may include headache, confusion, memory loss, dizziness, or loss of consciousness. Severe cases may require intensive medical intervention and rehabilitation. TBI is a major public health concern, with significant implications for patients and their families.
Get a Free Sample PDF Report to know more about Traumatic Brain Injury Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/traumatic-brain-injury-tbi-pipeline-insight [https://www.delveinsight.com/report-store/traumatic-brain-injury-tbi-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Emerging Traumatic Brain Injury Drugs Under Different Phases of Clinical Development Include:
*
Amantadine Hydrochloride: SHINKEI Therapeutics, Inc
*
HB-adMSCs: Hope Biosciences
*
[F-18]Flornaptitril: CereMark Pharma, LLC
*
ABX-101: Abalonex, LLC
*
Propranolol: Hamad Medical Corporation
*
MYOBLOC: Supernus Pharmaceuticals, Inc.
*
NT 201: Merz Pharmaceuticals GmbH
*
NTS-105: NeuroTrauma Sciences
*
Research Program: ALSP Inc.
*
ACD856: AlzeCure
*
PRV 002: Odyssey Group
*
PNT001: Pinteon Therapeutics
*
VAS203: Vasopharm
*
Vandefitemcel: SanBio
Traumatic Brain Injury Route of Administration
Traumatic Brain Injury pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
*
Oral
*
Parenteral
*
Intravenous
*
Subcutaneous
*
Topical
Traumatic Brain Injury Molecule Type
Traumatic Brain Injury Products have been categorized under various Molecule types, such as
*
Monoclonal Antibody
*
Peptides
*
Polymer
*
Small molecule
*
Gene therapy
Traumatic Brain Injury Pipeline Therapeutics Assessment
*
Traumatic Brain Injury Assessment by Product Type
*
Traumatic Brain Injury By Stage and Product Type
*
Traumatic Brain Injury Assessment by Route of Administration
*
Traumatic Brain Injury By Stage and Route of Administration
*
Traumatic Brain Injury Assessment by Molecule Type
*
Traumatic Brain Injury by Stage and Molecule Type
DelveInsight's Traumatic Brain Injury Report covers around products under different phases of clinical development like
*
Late-stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I)
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
*
Route of Administration
Further Traumatic Brain Injury product details are provided in the report. Download the Traumatic Brain Injury pipeline report to learn more about the emerging Traumatic Brain Injury therapies [https://www.delveinsight.com/sample-request/traumatic-brain-injury-tbi-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key companies in the Traumatic Brain Injury Therapeutics Market include:
Key companies developing therapies for Traumatic Brain Injury are - Neuren Pharmaceuticals Ltd., NeuroVive Pharmaceutical AB, Stemedica Cell Technologies Inc., Grace Laboratories LLC., Integra LifeSciences Corporation, Medtronic PLC, TEVA Pharmaceutical Industries Ltd., Vasopharm GmbH, among others.
Traumatic Brain Injury Pipeline Analysis:
The Traumatic Brain Injury pipeline report provides insights into
*
The report provides detailed insights about companies that are developing therapies for the treatment of Traumatic Brain Injury with aggregate therapies developed by each company for the same.
*
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Traumatic Brain Injury Treatment.
*
Traumatic Brain Injury key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
Traumatic Brain Injury Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Traumatic Brain Injury market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Traumatic Brain Injury drugs and therapies [https://www.delveinsight.com/sample-request/traumatic-brain-injury-tbi-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Traumatic Brain Injury Pipeline Market Drivers
*
Increase in the prevalence of Brain Injuries are some of the important factors that are fueling the Traumatic Brain Injury Market.
Traumatic Brain Injury Pipeline Market Barriers
*
However, less Robust pipeline, side-effects associated and other factors are creating obstacles in the Traumatic Brain Injury Market growth.
Scope of Traumatic Brain Injury Pipeline Drug Insight
*
Coverage: Global
*
Key Traumatic Brain Injury Companies: SHINKEI Therapeutics, Inc, Hope Biosciences, CereMark Pharma, LLC, Abalonex, LLC, Hamad Medical Corporation, Supernus Pharmaceuticals, Inc., Merz Pharmaceuticals GmbH, Odyssey Group, Pinteon Therapeutics, Vasopharm, SanBio, NeuroTrauma Sciences, ALSP Inc., AlzeCure, and others
*
Key Traumatic Brain Injury Therapies: Amantadine Hydrochloride, HB-adMSCs, [F-18]Flornaptitril, ABX-101, Propranolol, MYOBLOC, NT 201, PRV 002, PNT001, VAS203, Vandefitemcel, NTS-105, Research Program, ACD856, and others
*
Traumatic Brain Injury Therapeutic Assessment: Traumatic Brain Injury current marketed and Traumatic Brain Injury emerging therapies
*
Traumatic Brain Injury Market Dynamics: Traumatic Brain Injury market drivers and Traumatic Brain Injury market barriers
Request for Sample PDF Report for Traumatic Brain Injury Pipeline Assessment and clinical trials [https://www.delveinsight.com/sample-request/traumatic-brain-injury-tbi-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Traumatic Brain Injury Report Introduction
2. Traumatic Brain Injury Executive Summary
3. Traumatic Brain Injury Overview
4. Traumatic Brain Injury- Analytical Perspective In-depth Commercial Assessment
5. Traumatic Brain Injury Pipeline Therapeutics
6. Traumatic Brain Injury Late Stage Products (Phase II/III)
7. Traumatic Brain Injury Mid Stage Products (Phase II)
8. Traumatic Brain Injury Early Stage Products (Phase I)
9. Traumatic Brain Injury Preclinical Stage Products
10. Traumatic Brain Injury Therapeutics Assessment
11. Traumatic Brain Injury Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Traumatic Brain Injury Key Companies
14. Traumatic Brain Injury Key Products
15. Traumatic Brain Injury Unmet Needs
16 . Traumatic Brain Injury Market Drivers and Barriers
17. Traumatic Brain Injury Future Perspectives and Conclusion
18. Traumatic Brain Injury Analyst Views
19. Appendix
20. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=traumatic-brain-injury-pipeline-insights-2024-therapies-clinical-trials-and-treatment-outlook-neuren-pharma-neurovive-pharma-stemedica-cell-techn-grace-laboratories-integra-lifesciences-corp]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Traumatic Brain Injury Pipeline Insights 2024: Therapies, Clinical Trials, and Treatment Outlook | Neuren Pharma, NeuroVive Pharma, Stemedica Cell Techn, Grace Laboratories, Integra LifeSciences Corp here
News-ID: 3809487 • Views: …
More Releases from ABNewswire

The Debut Album of Soldier'z of the Most High (S.O.T.M.H): The City in the Sky N …
From sourthern roots and legendary encounters to a new sound called Salvation Music, Chattanooga's own Freddy Mac delivers his long-awaited debut album.
Chattanooga, TN - The wait is over. Freddy Mac 2025 and his band Soldier'z of the Most High (S.O.T.M.H) proudly unveil their long-anticipated debut album, The City in the Sky. This groundbreaking project introduces Salvation Music [http://www.salvationmusic.com], a bold fusion of funk, metal, soul, and classical influences, brought to…

Author's Tranquility Press Announces the Heartwarming Release of Lil' Hal's Gian …
A Christmas Tale of Wonder, Patience, and Family Love That Shines Beyond the Wrapping Paper
Few things capture the spirit of Christmas like the thrill of a child discovering a gift under the tree. In Lil' Hal's Giant Christmas Box [https://www.amazon.com/Lil-Hals-Giant-Christmas-Box/dp/195754662X/ref=monarch_sidesheet_title] by Christy B., readers are invited into a magical holiday morning filled with suspense, laughter, and an unforgettable lesson: sometimes the greatest gifts require patience, faith, and love.
This beautifully illustrated…

"The Expedia of VoIP": Business Phone System Disrupts Carrier Model with Transpa …
Business owners can now shop multiple providers at once-choosing the right system without sales pressure or hidden fees.
Sheridan, Wyoming - Business Phone System, a vendor-neutral platform for business communications, today announced its official launch, offering business owners a smarter way to evaluate and select telecom services. Unlike traditional carriers that push their own packages, Business Phone System enables organizations to compare multiple providers side-by-side, ensuring the right solution is sized…

Skerrit Bwoy Launches Explosive New Single "Satan Dead" - A Bold Christian EDM A …
Album Release: August 29, 2025
New York, NY - Antiguan-born, Bronx-raised producer and DJ Skerrit Bwoy, widely recognized as "Mr. Jesus Party", is set to shake the Christian music scene with the release of his latest single, "Satan Dead." Available today on all major streaming platforms, the track delivers a powerful fusion of festival-ready EDM drops, Caribbean dancehall vibes, and unapologetically Gospel-driven lyrics.
More than just a song, "Satan Dead" is a…
More Releases for Brain
Brain Training Apps Market Boosting the Brain: The Rise of Brain Training Apps a …
Brain Training Apps Market Assessment worth $ 44.43 Billion by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Brain Training Apps Market- by App Type (Memory, Attention, Language, Executive Function, Visual/spatial, and Other App Types), User Type (Android, iOS and Other User Types), Trends, Industry Competition Analysis, Revenue and Forecast To 2024-2031."
Get a free sample copy of…
Nutrient Survival Champions Brain Health During Alzheimer's & Brain Awareness Mo …
This June, Nutrient Survival is reminding people that nourishing your mind is as crucial as feeding your body, offering a revolutionary BrainCare® line.
Reno, NV (June 5, 2024) - As June marks Alzheimer's & Brain Awareness Month, Nutrient Survival, veteran-led pioneer in nutritional innovation, stands at the forefront of promoting
cognitive well-being with its revolutionary BrainCare® line and Brain Omega 3 Bar®. With alarming statistics highlighting the prevalence of brain-related ailments among…
Brain Monitoring Device Market - Harnessing the Power of Neurotechnology: Brain …
Newark, New Castle, USA: The "Brain Monitoring Device Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Brain Monitoring Device Market: https://www.growthplusreports.com/report/brain-monitoring-device-market/7889
This latest report researches the industry structure,…
Supercharge Your Brain: Revolutionary Brain Health Supplements for Improved Brai …
The global 𝐁𝐫𝐚𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐒𝐮𝐩𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐬 market is estimated to attain a significant valuation by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the Brain Health Supplements industry. The current…
Global Wearable Brain Devices Market Growth by 2030 - Advanced Brain Monitoring …
The research report based on the Global Wearable Brain Devices Industry offers the detailed study of each and every aspect coupled with the Wearable Brain Devices market. The report also analyzes all the strategic developments made in the Wearable Brain Devices sector. The research report offers detailed and accurate numerical data on costs, revenues, sales, profits, etc. The market report narrowly analyzes all the key growth factors that are considered…
Retro X Focus Nootropic Brain Booster - SUPERCHARGED BRAIN PERFORMANCE!
Retro X Focus Nootropic Brain Booster is a state-of-the-art nootropic that employs vitamins, vital nutrients, plus amino acids to assist you to think quicker, cleverer, smarten your memory, and improve attention and leave you feeling invigorated. The water-soluble extracts, which are useful in product additives, function to rejuvenate studying approaches and thinking.
Official Online Store - https://www.allnutritionhub.com/get-retro-x-focus-nootropic
How does the Retro X Focus Function?
It is common knowledge that we must work out…